Keep Harm at Bay: Oxidative Phosphorylation Induces Nrf2-Driven Antioxidant Response Via ERK5/MEF2/miR-23a Signaling to Keap-1

作者: Michael Danilenko , George P. Studzinski

DOI: 10.1016/J.EBIOM.2016.01.009

关键词:

摘要: Nuclear factor E2-related 2 (Nrf2) is a key transcription which induces the expression of various cellular antioxidant and detoxifying enzymes through binding transcriptional activation response elements (ARE) in promoters their genes. The Nrf2/ARE pathway known to protect cells against stress stimuli, primarily oxidative associated with increased production reactive oxygen species (ROS). Nrf2 activity tightly regulated by cytoplasmic inhibitory protein Kelch-like ECH-associated protein-1 (Keap-1) acts as an adaptor between cullin-3 ubiquitin ligase promotes rapid proteasomal degradation Nrf2. Being sensor exogenous endogenous electrophilic compounds ROS, Keap-1 undergoes conformational changes upon interaction such agents this causes release from complex, thus allowing it translocate nucleus transactivate Nrf2-responsive genes [see (Harder et al., 2015, Tebay 2015) for recent reviews]. In study, Khan al. (this issue) demonstrate that there also alternative mechanism whereby can be activated human leukemia performing phosphorylation (OXPHOS). authors found while OXPHOS results generation induction “classical” encoding heme oxygenase-1 (HO-1) NAD(P)H:quinone oxidoreductase (NQO1) occur ROS-independent manner. This was decrease mRNA levels, implying lower levels may facilitate stabilization de novo synthesized protein, increasing functional pathway. data show MAPK ERK5 upregulated system. suggests kinase responsible downregulation Keap-1, mediated downstream target ERK5, MEF2C. MEF2C binds promoter microRNA miR-23a–27a–24-2 cluster miR-23a destabilizes interacting its 3′-untranslated region (3'UTR). Taken together, suggest leukemic ERK5/MEF2/miR-23a signaling resulting leads pathway, protecting deleterious effects ROS. The findings are line previously reported ability microRNAs downregulate targeting 3′-UTR several types cancer (Eades 2011, Kabaria van Jaarsveld 2013). Interestingly, MEF2A were shown positively regulate different microRNAs, including miR-23a, vascular smooth muscle undergoing stress-induced senescence (Zhao cardiac myocytes mice myotonic dystrophy (Kalsotra 2014), respectively. Therefore, ERK5/MEF2/miR-23a/Keap-1 axis represent regulatory broad range cell under pathological conditions. The importance regulation hematopoiesis aberrations has been years [e.g., (Schotte 2012)]. For instance Gocek (2011) upregulation miR-32 1,25-dihydroxyvitamin D3 myeloid pro-apoptotic Bim, inhibition cytarabine-induced apoptosis, latter frequently result excess intracellular ROS. report demonstrates important connection alleviation stress. As such, indicate one basis emergence resistance cytotoxic chemotherapy neoplastic diseases. novel, ERK5/microRNA-dependent, mode suggested study adds mechanisms related hypermethylation inactivating mutations lead hyperactivation Nrf2/ARE, tumorigenesis chemoresistance (Zhang 2010)]. In scenario, anti-sense oligonucleotides block developed therapeutic fight consequences loss function Keap-1.

参考文章(11)
Lauren E. Tebay, Holly Robertson, Stephen T. Durant, Steven R. Vitale, Trevor M. Penning, Albena T. Dinkova-Kostova, John D. Hayes, Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease Free Radical Biology and Medicine. ,vol. 88, pp. 108- 146 ,(2015) , 10.1016/J.FREERADBIOMED.2015.06.021
Wang Zhao, Xi-Long Zheng, Dao-Quan Peng, Shui-Ping Zhao, Myocyte Enhancer Factor 2A Regulates Hydrogen Peroxide-Induced Senescence of Vascular Smooth Muscle Cells Via microRNA-143. Journal of Cellular Physiology. ,vol. 230, pp. 2202- 2211 ,(2015) , 10.1002/JCP.24948
Savan Kabaria, Doo Chul Choi, Amrita Datta Chaudhuri, Mohit Raja Jain, Hong Li, Eunsung Junn, MicroRNA-7 activates Nrf2 pathway by targeting Keap1 expression. Free Radical Biology and Medicine. ,vol. 89, pp. 548- 556 ,(2015) , 10.1016/J.FREERADBIOMED.2015.09.010
M T M van Jaarsveld, J Helleman, A W M Boersma, P F van Kuijk, W F van IJcken, E Despierre, I Vergote, R H J Mathijssen, E M J J Berns, J Verweij, J Pothof, E A C Wiemer, miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene. ,vol. 32, pp. 4284- 4293 ,(2013) , 10.1038/ONC.2012.433
Gabriel Eades, Muhua Yang, Yuan Yao, Yongshu Zhang, Qun Zhou, miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer Cells Journal of Biological Chemistry. ,vol. 286, pp. 40725- 40733 ,(2011) , 10.1074/JBC.M111.275495
Auinash Kalsotra, Ravi K. Singh, Priyatansh Gurha, Amanda J. Ward, Chad J. Creighton, Thomas A. Cooper, The Mef2 Transcription Network Is Disrupted in Myotonic Dystrophy Heart Tissue, Dramatically Altering miRNA and mRNA Expression Cell Reports. ,vol. 6, pp. 336- 345 ,(2014) , 10.1016/J.CELREP.2013.12.025
D Schotte, R Pieters, M L Den Boer, MicroRNAs in acute leukemia: from biological players to clinical contributors Leukemia. ,vol. 26, pp. 1- 12 ,(2012) , 10.1038/LEU.2011.151
Ping Zhang, Anju Singh, Srinivasan Yegnasubramanian, David Esopi, Ponvijay Kombairaju, Manish Bodas, Hailong Wu, Steven G. Bova, Shyam Biswal, Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth Molecular Cancer Therapeutics. ,vol. 9, pp. 336- 346 ,(2010) , 10.1158/1535-7163.MCT-09-0589
Bryan Harder, Tao Jiang, Tongde Wu, Shasha Tao, Montserrat Rojo de la Vega, Wang Tian, Eli Chapman, Donna D. Zhang, Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention. Biochemical Society Transactions. ,vol. 43, pp. 680- 686 ,(2015) , 10.1042/BST20150020
Elzbieta Gocek, Xuening Wang, Xiuping Liu, Chang-Gong Liu, George P. Studzinski, MicroRNA-32 Upregulation by 1,25-Dihydroxyvitamin D3 in Human Myeloid Leukemia Cells Leads to Bim Targeting and Inhibition of AraC-Induced Apoptosis Cancer Research. ,vol. 71, pp. 6230- 6239 ,(2011) , 10.1158/0008-5472.CAN-11-1717